Skip to main content
PMC home page
American Journal of Public Health logoLink to American Journal of Public Health
. 1991 Sep;81(9):1180–1184. doi: 10.2105/ajph.81.9.1180

Factors influencing the formation of new human coronary lesions: age, blood pressure, and blood cholesterol.

W J Mack 1, D H Blankenhorn 1
PMCID: PMC1405634  PMID: 1951831

Abstract

BACKGROUND. The Cholesterol Lowering Atherosclerosis Study, a controlled angiographic trial, has reported that new native coronary artery lesions are significantly reduced by aggressive blood lipid lowering therapy with colestipol plus niacin. To study factors relevant to primary atherosclerosis prevention, we have conducted an epidemiologic analysis of new native coronary lesion formation in placebo-treated patients. METHODS. Univariate and multivariate logistic regression procedures were used to examine age at entry into the study, number of years since bypass, body weight, diastolic and systolic blood pressure, plasma total cholesterol, triglycerides, HDL-cholesterol, LDL-cholesterol, non-HDL-cholesterol, and apolipoproteins A-I,B, and C-III. RESULTS. Significant univariate protective factors were older age (P less than .006), reduction of total plasma cholesterol (P less than .040), and systolic (P less than .024) and diastolic (P less than .022) blood pressure. Significant multivariate protective factors were older age (P less than .005) and reduction in systotic blood pressure (P less than .021). Blood pressure effects were not associated with use of specific antihypertensive agents. CONCLUSIONS. These data provide additional support for the control of hypertension and reduction of blood cholesterol level for primary and secondary ischemic heart disease prevention. They also indicate the existence of a population at high risk for early coronary lesion formation and the need for improved means to identify such individuals prior to the onset of clinical manifestations of ischemic heart disease.

Full text

PDF
1181

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arntzenius A. C., Kromhout D., Barth J. D., Reiber J. H., Bruschke A. V., Buis B., van Gent C. M., Kempen-Voogd N., Strikwerda S., van der Velde E. A. Diet, lipoproteins, and the progression of coronary atherosclerosis. The Leiden Intervention Trial. N Engl J Med. 1985 Mar 28;312(13):805–811. doi: 10.1056/NEJM198503283121301. [DOI] [PubMed] [Google Scholar]
  2. Bemis C. E., Gorlin R., Kemp H. G., Herman M. V. Progression of coronary artery disease. A clinical arteriographic study. Circulation. 1973 Mar;47(3):455–464. doi: 10.1161/01.cir.47.3.455. [DOI] [PubMed] [Google Scholar]
  3. Blankenhorn D. H., Johnson R. L., Mack W. J., el Zein H. A., Vailas L. I. The influence of diet on the appearance of new lesions in human coronary arteries. JAMA. 1990 Mar 23;263(12):1646–1652. [PubMed] [Google Scholar]
  4. Blankenhorn D. H., Johnson R. L., Nessim S. A., Azen S. P., Sanmarco M. E., Selzer R. H. The Cholesterol Lowering Atherosclerosis Study (CLAS): design, methods, and baseline results. Control Clin Trials. 1987 Dec;8(4):356–387. doi: 10.1016/0197-2456(87)90156-5. [DOI] [PubMed] [Google Scholar]
  5. Blankenhorn D. H., Nessim S. A., Johnson R. L., Sanmarco M. E., Azen S. P., Cashin-Hemphill L. Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts. JAMA. 1987 Jun 19;257(23):3233–3240. [PubMed] [Google Scholar]
  6. Brensike J. F., Levy R. I., Kelsey S. F., Passamani E. R., Richardson J. M., Loh I. K., Stone N. J., Aldrich R. F., Battaglini J. W., Moriarty D. J. Effects of therapy with cholestyramine on progression of coronary arteriosclerosis: results of the NHLBI Type II Coronary Intervention Study. Circulation. 1984 Feb;69(2):313–324. doi: 10.1161/01.cir.69.2.313. [DOI] [PubMed] [Google Scholar]
  7. Bruschke A. V., Wijers T. S., Kolsters W., Landmann J. The anatomic evolution of coronary artery disease demonstrated by coronary arteriography in 256 nonoperated patients. Circulation. 1981 Mar;63(3):527–536. doi: 10.1161/01.cir.63.3.527. [DOI] [PubMed] [Google Scholar]
  8. Cohn K., Sakai F. J., Langston M. F., Jr Effect of clofibrate on progression of coronary disease: a prospective angiographic study in man. Am Heart J. 1975 May;89(5):591–598. doi: 10.1016/0002-8703(75)90504-9. [DOI] [PubMed] [Google Scholar]
  9. Deupree R. H., Fields R. I., McMahan C. A., Strong J. P. Atherosclerotic lesions and coronary heart disease. Key relationships in necropsied cases. Lab Invest. 1973 Feb;28(2):252–262. [PubMed] [Google Scholar]
  10. Friedewald W. T., Levy R. I., Fredrickson D. S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972 Jun;18(6):499–502. [PubMed] [Google Scholar]
  11. Henderson R. R., Rowe G. G. The progression of coronary atherosclerotic disease as assessed by cine-coronary arteriography. Am Heart J. 1973 Aug;86(2):165–172. doi: 10.1016/0002-8703(73)90240-8. [DOI] [PubMed] [Google Scholar]
  12. Kannel W. B., Gordon T. The search for an optimum serum cholesterol. Lancet. 1982 Aug 14;2(8294):374–375. doi: 10.1016/s0140-6736(82)90558-x. [DOI] [PubMed] [Google Scholar]
  13. Keys A., Menotti A., Karvonen M. J., Aravanis C., Blackburn H., Buzina R., Djordjevic B. S., Dontas A. S., Fidanza F., Keys M. H. The diet and 15-year death rate in the seven countries study. Am J Epidemiol. 1986 Dec;124(6):903–915. doi: 10.1093/oxfordjournals.aje.a114480. [DOI] [PubMed] [Google Scholar]
  14. Kimbiris D., Lavine P., Van Den Broek H., Najmi M., Likoff W. Devolutionary pattern of coronary atherosclerosis in patients with angina pectoris. Coronary arteriographic studies. Am J Cardiol. 1974 Jan;33(1):7–11. doi: 10.1016/0002-9149(74)90732-2. [DOI] [PubMed] [Google Scholar]
  15. Kuo P. T., Hayase K., Kostis J. B., Moreyra A. E. Use of combined diet and colestipol in long-term (7--7 1/2 years) treatment of patients with type II hyperlipoproteinemia. Circulation. 1979 Feb;59(2):199–211. doi: 10.1161/01.cir.59.2.199. [DOI] [PubMed] [Google Scholar]
  16. Marchandise B., Bourassa M. G., Chaitman B. R., Lesperance J. Angiographic evaluation of the natural history of normal coronary arteries and mild coronary atherosclerosis. Am J Cardiol. 1978 Feb;41(2):216–220. doi: 10.1016/0002-9149(78)90159-5. [DOI] [PubMed] [Google Scholar]
  17. McLaughlin P. R., Berman N. D., Morton B. C., Schwartz L., Morch J. E. Long-term angiographic assessment of the influence of coronary risk factors on native coronary circulation and saphenous vein aortocoronary grafts. Am Heart J. 1977 Mar;93(3):327–333. doi: 10.1016/s0002-8703(77)80252-4. [DOI] [PubMed] [Google Scholar]
  18. Moise A., Théroux P., Taeymans Y., Waters D. D., Lespérance J., Fines P., Descoings B., Robert P. Clinical and angiographic factors associated with progression of coronary artery disease. J Am Coll Cardiol. 1984 Mar;3(3):659–667. doi: 10.1016/s0735-1097(84)80240-5. [DOI] [PubMed] [Google Scholar]
  19. Nash D. T., Gensini G., Esente P. Effect of lipid-lowering therapy on the progression of coronary atherosclerosis assessed by scheduled repetitive coronary arteriography. Int J Cardiol. 1982;2(1):43–55. doi: 10.1016/0167-5273(82)90008-0. [DOI] [PubMed] [Google Scholar]
  20. Nikkilä E. A., Viikinkoski P., Valle M., Frick M. H. Prevention of progression of coronary atherosclerosis by treatment of hyperlipidaemia: a seven year prospective angiographic study. Br Med J (Clin Res Ed) 1984 Jul 28;289(6439):220–223. doi: 10.1136/bmj.289.6439.220. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Pearson T. A. Coronary arteriography in the study of the epidemiology of coronary artery disease. Epidemiol Rev. 1984;6:140–166. doi: 10.1093/oxfordjournals.epirev.a036269. [DOI] [PubMed] [Google Scholar]
  22. Rafflenbeul W., Smith L. R., Rogers W. J., Mantle J. A., Rackley C. E., Russell R. O., Jr Quantitative coronary arteriography. Coronary anatomy of patients with unstable angina pectoris reexamined 1 year after optimal medical therapy. Am J Cardiol. 1979 Apr;43(4):699–707. doi: 10.1016/0002-9149(79)90066-3. [DOI] [PubMed] [Google Scholar]
  23. Raichlen J. S., Healy B., Achuff S. C., Pearson T. A. Importance of risk factors in the angiographic progression of coronary artery disease. Am J Cardiol. 1986 Jan 1;57(1):66–70. doi: 10.1016/0002-9149(86)90953-7. [DOI] [PubMed] [Google Scholar]
  24. Shea S., Sciacca R. R., Esser P., Han J., Nichols A. B. Progression of coronary atherosclerotic disease assessed by cinevideodensitometry: relation to clinical risk factors. J Am Coll Cardiol. 1986 Dec;8(6):1325–1331. doi: 10.1016/s0735-1097(86)80304-7. [DOI] [PubMed] [Google Scholar]

Articles from American Journal of Public Health are provided here courtesy of American Public Health Association

RESOURCES